Chemotherapy :: Role of antioxidants in reducing chemotherapy toxicity

A new study showing a reduction in the toxic side effects of ROS-generating chemotherapies with concurrent antioxidant supplementation will be presented at the 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO) that takes place June 1-5 at McCormick Place in Chicago.

Urology :: NYP/Weill Cornell Urologists present at 2007 AUA Conference

NewYork-Presbyterian Hospital/Weill Cornell Medical Center urologists are presenting exciting new research at the 2007 American Urological Association (AUA) Conference in Anaheim, May 19?May 24. Among the most significant presentations are the following:

Hepatitis C :: Schering-Plough presenting Hepatitis C at Digestive Disease Week 2007 Annual Meeting

A total of 20 oral and poster presentations on clinical studies with Schering-Plough’s hepatitis products, including PEGINTRON(TM) (peginterferon alfa-2b) and REBETOL(R) (ribavirin, USP) combination therapy for chronic hepatitis C virus (HCV) infection, as well as boceprevir (SCH 503034), the company’s investigational oral HCV protease inhibitor currently in Phase II clinical development, will be presented by leading researchers at the 38th annual Digestive Disease Week (DDW) meeting to be held at the Washington Convention Center in Washington, D.C., May 20-23.